Diabetes News and Research

Latest Diabetes News and Research

Many countries have a long way to go to reduce suffering, deaths from non-communicable disease

A new method published in the Lancet of monitoring countries' performance in reducing the burden of NCD (non-communicable disease), shows that many countries have a long way to go to reduce suffering and deaths from NCD.

26 Sep 2015

New Kaiser Permanente study finds small decline in obesity rates among young people in Southern California

A new study from Kaiser Permanente found a small but significant decline in the percentage of young people who are overweight and obese in Southern California. The decline was seen across all ages, races and ethnicities, but was less pronounced in girls, adolescents, Hispanic and black children, according to the results published today in The Journal of Pediatrics.

26 Sep 2015

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration approved the new drug application for Tresiba (insulin degludec injection), a once-daily, long-acting basal insulin. Tresiba is indicated for use alone, or in combination with oral antidiabetic medicines or bolus insulin, and is approved for glycemic control in adults with type 1 and type 2 diabetes. Tresiba provides a long duration of action beyond 42 hours.

From Novo Nordisk 26 Sep 2015

Researchers identify new biochemical pathway that could be a potential target for insulin control

In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.

25 Sep 2015

Prevalence of frailty in older people varies by region and race

A large-scale survey of older Americans living at home or in assisted living settings found that 15 percent are frail, a diminished state that makes people more vulnerable to falls, chronic disease and disability, while another 45 percent are considered pre-frail, or at heightened risk of becoming physically diminished.

25 Sep 2015

Medication used for diabetes could be a valuable tool for treating alcohol dependence

A new study on mice and rats at Sahlgrenska Academy shows that a medication used for diabetes and obesity also could be a valuable tool for the treatment of alcohol dependence.

25 Sep 2015

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

EKF, announces the UK launch of the Altair™ 240 clinical chemistry analyser at the Institute of Biomedical Science Congress 2015 in Birmingham.

From EKF Diagnostics 24 Sep 2015

Fidgeting while sitting may be good for us

Fidgeting may counteract the adverse health effects of sitting down for long periods, according to a new study published in the American Journal of Preventive Medicine.

24 Sep 2015

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company), today announced the availability of the U.S. Food and Drug Administration cleared BD MAX Enteric Parasite Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 24 Sep 2015

Moderate beer consumption protects women from heart attacks

Women who drink beer at most once or twice per week run a 30 per cent lower risk of heart attack, compared with both heavy drinkers and women who never drink beer. These are the findings of a Swedish study which has followed 1,500 women over a period of almost 50 years.

24 Sep 2015

Duke Raleigh Hospital becomes first healthcare facility to use certified mobile compounding cleanroom

Duke Raleigh Hospital recently became the first healthcare facility to utilize a certified USP 797 mobile cleanroom to assure uninterrupted pharmacy services. The advanced pharmacy unit, created by Germfree Labs, allowed the hospital to maintain separate, on-site sterile drug compounding operations during a major renovation project.

24 Sep 2015

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Resverlogix Corp. announced today the commencement of an Orphan Disease Program specific for Complement Mediated Diseases. New data generated by Resverlogix has demonstrated that BET inhibition by apabetalone (RVX-208) has effects on multiple biological pathways that underlie disease pathology.

24 Sep 2015

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.

24 Sep 2015

Feeling dizzy after standing up may signal serious conditions, increased risk of death

People who get dizzy several minutes after standing up may be at risk of more serious conditions and even an increased risk of death, according to new research published in the September 23, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

24 Sep 2015

City of Hope receives gift to open new Judy and Bernard Briskin Center for Multiple Myeloma Research

The Judy and Bernard Briskin Family Foundation has announced a gift to launch the new Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope, the third named center within City of Hope's new Hematologic Malignancies and Stem Cell Transplantation Institute. The generous gift will enable the institution to further its already considerable accomplishments in the field of myeloma treatment and research.

24 Sep 2015

Novel approach promises easier way to detect protein fibers implicated in neuro-degenerative diseases

Liquid crystals are familiar to most of us as the somewhat humdrum stuff used to make computer displays and TVs. Even for scientists, it has not been easy to find other ways of using them.

24 Sep 2015

FIT publishes 3rd Edition of Injection Technique Recommendations

The Forum for Injection Technique UK has published the 3rd Edition of its Injection Technique Recommendations, featuring contributions from over 65 clinical experts, along with data from the latest research studies and all new imagery and graphics.

24 Sep 2015

NGN3-expressing cells in adult human pancreas offer hope to diabetics

Cells that express neurogenin 3 (NGN3) may one day be harnessed to create a plentiful supply of insulin-producing beta cells for the treatment of diabetes, a study led by researchers at the University of South Florida suggests.

24 Sep 2015

Researchers extend innovative research towards a cure for type I diabetes

Associate Professor Shane Grey, of Sydney's Garvan Institute of Medical Research, together with collaborators from the Westmead Millennium Institute for Medical Research and the Children's Hospital at Westmead, have been awarded $3.3 million to extend their innovative research towards a cure for type I diabetes.

23 Sep 2015

IUPUI awarded grant to develop breathalyzer-type device for detecting hypoglycemia in diabetes people

A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.

23 Sep 2015

Diabetes News and Research

Latest Diabetes News and Research

Many countries have a long way to go to reduce suffering, deaths from non-communicable disease

New Kaiser Permanente study finds small decline in obesity rates among young people in Southern California

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Researchers identify new biochemical pathway that could be a potential target for insulin control

Prevalence of frailty in older people varies by region and race

Medication used for diabetes could be a valuable tool for treating alcohol dependence

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

Fidgeting while sitting may be good for us

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

Moderate beer consumption protects women from heart attacks

Duke Raleigh Hospital becomes first healthcare facility to use certified mobile compounding cleanroom

Pabetalone (RVX-208) to be tested in proof-of-concept pilot study in complement mediated diseases

Alimera Sciences announces results from ongoing study on ILUVIEN

Feeling dizzy after standing up may signal serious conditions, increased risk of death

City of Hope receives gift to open new Judy and Bernard Briskin Center for Multiple Myeloma Research

Novel approach promises easier way to detect protein fibers implicated in neuro-degenerative diseases

FIT publishes 3rd Edition of Injection Technique Recommendations

NGN3-expressing cells in adult human pancreas offer hope to diabetics

Researchers extend innovative research towards a cure for type I diabetes

IUPUI awarded grant to develop breathalyzer-type device for detecting hypoglycemia in diabetes people

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in